Abdulhaq, H., Lundberg, L., Belousov, A., Relf, J., Linacre, R., Gregory, G. P. (2025). CRS-RS.5p predictive model informs risk stratification and cytokine release syndrome management following glofitamab treatment in patients with relapsed or refractory diffuse large B-cell lymphoma. Blood. https://doi.org/10.1182/blood-2025-2559